Corvus Pharmaceuticals, Inc. (CRVS) › Shares OutstandingCorvus Pharmaceuticals, Inc. (CRVS) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 1.43M2016: 20.92M2017: 21.04M2018: 29.32M2019: 27.95M2020: 28.37M2021: 46.55M2022: 46.55M2023: 49.04M2024: 67.90M2025: 74.70M74.70M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202574.70M+10.0%202467.90M+38.5%202349.04M+5.3%202246.55M+0.0%202146.55M+64.1%202028.37M+1.5%201927.95M-4.7%201829.32M+39.4%201721.04M+0.6%201620.92M+1361.5%20151.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share